Nelarabine
- Product NDC
- 25021-259
- 11-digit product format
- 250210259
- Labeler code
- 25021
- Product ID
- 25021-259_c956537f-71c0-44bc-a2e2-ab2adaa4f756
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nelarabine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA212605
- Marketing category
- ANDA
- Marketing start
- 2024-08-01
- Substance
- NELARABINE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 60158CV180 | NELARABINE | 121032-29-9 | NELARABINE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-259-50 | 25021025950 | 1 VIAL in 1 CARTON (25021-259-50) / 50 mL in 1 VIAL | 1 vial | 2024-08-01 | No | No | Historical |
| 25021-259-51 | 25021025951 | 6 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL | 6 vial | 2024-08-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Nelarabine | Sagent Pharmaceuticals | 2024-05-28 | HUMAN PRESCRIPTION DRUG LABEL | 1 |